Organogenesis Holdings Inc (ORGO) Stock Analysis

Organogenesis Holdings Inc (ORGO) is a publicly traded company in the HEALTHCARE sector. It trades at $2.24, carries a market capitalization of $303.67M. This page summarizes the public market data, fundamentals, and frequently asked questions for ORGO, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

Market Sentiment

Organogenesis Holdings Inc currently has a Bearish sentiment score of -0.31.

About Organogenesis Holdings Inc

Organogenesis Holdings Inc. (ORGO) is a prominent leader in regenerative medicine, dedicated to advancing patient care through its innovative allograft products and bioactive wound care therapies aimed at the advanced wound care, surgical, and sports medicine sectors in the United States. Based in Canton, Massachusetts, the company emphasizes scientific innovation and quality in its offerings, catering to the increasing demand for effective regenerative healthcare solutions. With a strong foc...

GNG Research Analysis

GNG Research scores Organogenesis Holdings Inc (ORGO) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for ORGO.

Frequently Asked Questions

Does ORGO pay dividends?

Organogenesis Holdings Inc (ORGO) does not currently pay a regular dividend.

What is ORGO's market cap?

Organogenesis Holdings Inc (ORGO) has a market capitalization of $303.67M with a current stock price of $2.24.